Christopher Corbett

Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial

Philip N. Newsome, Richard Fox, Andrew King et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 151 citations · Full text

Injectable microcryogels reinforced alginate encapsulation of mesenchymal stromal cells for leak-proof delivery and alleviation of canine disc degeneration

Yang Zeng, Chun Chen, Wei Liu et al. · Biomaterials · 2015 · 137 citations

Tissue Engineering, Regenerative Medicine, Engineering +11

Optimising risk stratification in primary biliary cirrhosis: AST/platelet ratio index predicts outcome independent of ursodeoxycholic acid response

Palak Trivedi, Tony Bruns, Angela Cheung et al. · Journal of Hepatology · 2014 · 131 citations

Hepatology, Biliary Tract, Medicine +10

Postnatal Erythropoietin Mitigates Impaired Cerebral Cortical Development Following Subplate Loss from Prenatal Hypoxia–Ischemia

Lauren L. Jantzie, Christopher Corbett, Daniel J. Firl et al. · Cerebral Cortex · 2014 · 76 citations · Full text

Hepatic ischemia reperfusion injury is associated with acute kidney injury following donation after brain death liver transplantation

Joanna Leithead, Matthew J. Armstrong, Christopher Corbett et al. · Transplant International · 2013 · 71 citations